Cargando…
The optimal dose of Ramelteon for the better treatment adherence of delayed sleep–wake phase disorder: a dropout rate study
BACKGROUND: Evidence regarding the effectiveness of melatonin receptor agonists in treating delayed sleep–wake phase disorder (DSWPD) remains limited. This study aimed to determine the optimal dose of ramelteon, a melatonin receptor agonist, for the better treatment adherence of DSWPD. METHODS: The...
Autores principales: | Takagi, Shunsuke, Sugihara, Genichi, Takahashi, Hidehiko, Inoue, Yuichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568065/ https://www.ncbi.nlm.nih.gov/pubmed/37840911 http://dx.doi.org/10.3389/fneur.2023.1280131 |
Ejemplares similares
-
Ramelteon for Delayed Sleep-wake Phase Disorder: A Case Report
por: Takeshima, Masahiro, et al.
Publicado: (2020) -
Evaluation of the Anxiolytic Effect of Ramelteon in Various Rat Models of Anxiety
por: Nachiappan, KR, et al.
Publicado: (2023) -
Hyperfocus symptom and internet addiction in individuals with attention-deficit/hyperactivity disorder trait
por: Ishii, Sayuri, et al.
Publicado: (2023) -
A review of ramelteon in the treatment of sleep disorders
por: Neubauer, David N
Publicado: (2008) -
Non‐24‐hour sleep‐wake disorder successfully treated with the combination of ramelteon and suvorexant in a case of autism spectrum disorder
por: Iwata, Masaaki, et al.
Publicado: (2020)